Breast cancer that is HER2 3+ by IHC or HER2 2+ by IHC with ISH (in situ hybridization) amplification is defined as HER2-amplified breast cancer, while others are defined as HER2 non-amplified. This evidence concerns the gene ERBB2 and breast carcinoma.